27 results
S-1
EX-10.5
ALGS
Aligos Therapeutics Inc
25 Sep 20
IPO registration
5:27pm
been so sold or transferred.
10.10 Data Privacy. As a condition of receipt of any Award, each Participant explicitly and unambiguously consents … have different data privacy laws and protections than the recipients’ country. Through acceptance of an Award, each Participant authorizes
S-1/A
EX-10.6
ALGS
Aligos Therapeutics Inc
9 Oct 20
IPO registration (amended)
5:26pm
undertakes to handle and defend it on his or her own behalf.
11.8 Data Privacy. As a condition for receiving any Award, each Participant explicitly … may have different data privacy laws and protections than the recipients’ country. By accepting an Award, each Participant authorizes such recipients
S-1
EX-10.5
ALGS
Aligos Therapeutics Inc
25 Sep 20
IPO registration
5:27pm
will hold, collect and otherwise process certain data as set out in the applicable Company’s GDPR-compliant data privacy notice, which will be or has been
S-1/A
EX-10.7
ALGS
Aligos Therapeutics Inc
9 Oct 20
IPO registration (amended)
5:26pm
, conversion of local currency, data privacy security, payroll tax, withholding procedures, establishment of bank or trust accounts to hold payroll deductions
10-K
ko7gb1w ybwcdmlubdxo
23 Mar 21
Annual report
4:26pm
S-1
gfe2hf7rkaq
25 Sep 20
IPO registration
5:27pm
424B4
pvjw7
19 Oct 20
Prospectus supplement with pricing info
5:21pm
DRS
i11yn
26 Aug 20
Draft registration statement
12:00am
S-1/A
x6lrr
9 Oct 20
IPO registration (amended)
5:26pm
10-Q
m30ilf1wjofqpl
25 Nov 20
Quarterly report
5:21pm